Additional file 5 of The cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysis

Additional file 5: Fig. S5. Analysis of tumor mutation, TIDE, immune checkpoints of tumor signature genes in gliomas. A A scatter plot showing TMB was positively correlated with the CRG score. B The characteristics of the top 10 most frequently mutated genes and variant classification. Scatter plot showing the correlation of TIDE, dysfunction, exclusion, and MSI with immune (C-F) and CRG (G-J) scores. K Analysis of immune checkpoints between CRG risk subgroups. L Heatmap illustrating the relationships among CRG risk subgroups, clinical profiles, and 22 types of immune cells. *p < 0.05;**p < 0.01;***p < 0.001.